512 related articles for article (PubMed ID: 11865341)
1. Metastatic differentiated thyroid carcinoma: clinicopathological profile and outcome in an iodine deficient area.
Mishra A; Mishra SK; Agarwal A; Das BK; Agarwal G; Gambhir S
World J Surg; 2002 Feb; 26(2):153-7. PubMed ID: 11865341
[TBL] [Abstract][Full Text] [Related]
2. Lung metastases in patients with differentiated thyroid carcinoma and evaluation of response to radioiodine therapy.
Kalender E; Zeki Celen Y; Elboga U; Deniz Demir H; Yilmaz M
Rev Esp Med Nucl Imagen Mol; 2012; 31(6):328-31. PubMed ID: 23084016
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of differentiated thyroid carcinoma in children and adolescents from a sub-Himalayan iodine-deficient endemic zone.
Bal CS; Padhy AK; Kumar A
Nucl Med Commun; 2001 Aug; 22(8):881-7. PubMed ID: 11473207
[TBL] [Abstract][Full Text] [Related]
4. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
[TBL] [Abstract][Full Text] [Related]
5. Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine.
Chow SM; Law SC; Mendenhall WM; Au SK; Yau S; Mang O; Lau WH
Pediatr Blood Cancer; 2004 Feb; 42(2):176-83. PubMed ID: 14752883
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature.
Qu N; Zhang L; Lu ZW; Ji QH; Yang SW; Wei WJ; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7797-808. PubMed ID: 26695148
[TBL] [Abstract][Full Text] [Related]
7. Occult distant metastases of well-differentiated thyroid carcinoma.
Zohar Y; Strauss M
Head Neck; 1994; 16(5):438-42. PubMed ID: 7960741
[TBL] [Abstract][Full Text] [Related]
8. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.
Dottorini ME; Vignati A; Mazzucchelli L; Lomuscio G; Colombo L
J Nucl Med; 1997 May; 38(5):669-75. PubMed ID: 9170425
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of differentiated thyroid carcinoma: experience in a developing country.
Bhargav PR; Mishra A; Agarwal G; Agarwal A; Pradhan PK; Gambhir S; Verma AK; Mishra SK
World J Surg; 2010 Jan; 34(1):40-7. PubMed ID: 20020292
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma -- surgery or conventional therapy?
Zettinig G; Fueger BJ; Passler C; Kaserer K; Pirich C; Dudczak R; Niederle B
Clin Endocrinol (Oxf); 2002 Mar; 56(3):377-82. PubMed ID: 11940050
[TBL] [Abstract][Full Text] [Related]
11. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
12. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
[TBL] [Abstract][Full Text] [Related]
13. Clinical management and outcomes in patients with hyperfunctioning distant metastases from differentiated thyroid cancer after total thyroidectomy and radioactive iodine therapy.
Qiu ZL; Shen CT; Luo QY
Thyroid; 2015 Feb; 25(2):229-37. PubMed ID: 25331724
[TBL] [Abstract][Full Text] [Related]
14. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
[TBL] [Abstract][Full Text] [Related]
15. Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases.
Filesi M; Signore A; Ventroni G; Melacrinis FF; Ronga G
J Nucl Med; 1998 Sep; 39(9):1542-6. PubMed ID: 9744339
[TBL] [Abstract][Full Text] [Related]
16. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
17. Distribution of Na+/I- symporter in thyroid cancers in an iodine-deficient population: an immunohistochemical study.
Mishra A; Pal L; Mishra SK
World J Surg; 2007 Sep; 31(9):1737-1742. PubMed ID: 17653791
[TBL] [Abstract][Full Text] [Related]
18. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
Haq M; Harmer C
Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
[TBL] [Abstract][Full Text] [Related]
19. Is it still worthwhile to treat bone metastases from differentiated thyroid carcinoma with radioactive iodine?
Proye CA; Dromer DH; Carnaille BM; Gontier AJ; Goropoulos A; Carpentier P; Lefebvre J; Decoulx M; Wemeau JL; Fossati P
World J Surg; 1992; 16(4):640-5; discussion 645-6. PubMed ID: 1384244
[TBL] [Abstract][Full Text] [Related]
20. [Results of radioiodine therapy in patients with pulmonary metastases of differentiated thyroid cancer].
Ono Y; Yamamoto Y; Nishiyama Y; Nakano S; Takahashi K; Kawasaki Y; Satoh K; Ohkawa M; Tanabe M
Kaku Igaku; 2000 Nov; 37(6):661-70. PubMed ID: 11193452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
